• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: EDWARDS LIFESCIENCES EDWARDS SAPIEN 3 ULTRA TRANSCATHETER HEART VALVE; AORTIC VALVE, PROSTHESIS, PERCUTANEOUSLY DELIVERED

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

EDWARDS LIFESCIENCES EDWARDS SAPIEN 3 ULTRA TRANSCATHETER HEART VALVE; AORTIC VALVE, PROSTHESIS, PERCUTANEOUSLY DELIVERED Back to Search Results
Model Number 9750TFX26
Device Problem Malposition of Device (2616)
Patient Problem Cardiac Arrest (1762)
Event Date 02/06/2023
Event Type  Injury  
Event Description
As reported from our affiliates in brazil, this was a case of a 26mm sapien 3 ultra valve in aortic position by transfemoral approach.During device preparation, the 26mm sapien 3 ultra was mistakenly crimped in the inverted position.The system and crimped valve were reviewed before introducing into the patient as per protocol.The 26mm sapien 3 ultra valve was implanted and patient had cardiorespiratory arrest until the crimping error was detected.A new 26mm valve was correctly prepared and implanted in the patient.The patient left the room hemodynamically unstable and remained in serious condition in the intensive care unit (icu) using vasoactive drugs and mechanical ventilation.Per follow up, the patient was conscious, oriented, without neurological damage, and on spontaneous ventilation.The patient was discharged without sequelae from the event after a prolonged icu stay post-procedure due to pneumonia that arose during hospitalization.Per medical opinion, the root cause of the event was human error.
 
Manufacturer Narrative
Investigation is ongoing.
 
Manufacturer Narrative
Updated h6-type of investigation, investigation findings, investigation conclusions.The device was not returned for evaluation.The complaint for implantation of incorrectly oriented valve was unable to be confirmed.The reported event does not allege a device malfunction that could be related to an edwards manufacturing deficiency.A review of ifu/training materials revealed no deficiencies.A review of edwards lifesciences risk management documentation was performed for this case.The reported events are an anticipated risk of the transcatheter heart valve (thv) procedure, additional assessment of the failure modes is not required at this time.As reported, "during device preparation, the 26mm sapien 3 ultra was mistakenly crimped in the inverted position.The system and crimped valve were reviewed before introducing into the patient as per protocol.The 26mm sapien 3 ultra valve was implanted and patient had cardiorespiratory arrest until the crimping error was detected." device preparation and procedure training manual instructs to verify thv orientation prior to inserting the delivery system into the sheath.In this case, both the hospital tech, who crimped the valve, and the operating physician failed to identify that the valve was crimped in incorrect orientation.As such, available information suggests that procedural factors (failure to identify incorrect orientation of the valve) may have contributed to the complaint event.Complaint histories for all reported events are reviewed against trending control limits monthly, and any excursions above the control limits are assessed and documented as part of this monthly review.No corrective or preventative actions are required.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
EDWARDS SAPIEN 3 ULTRA TRANSCATHETER HEART VALVE
Type of Device
AORTIC VALVE, PROSTHESIS, PERCUTANEOUSLY DELIVERED
Manufacturer (Section D)
EDWARDS LIFESCIENCES
1 edwards way
irvine CA 92614
Manufacturer Contact
renee van dorne
1 edwards way
irvine, CA 92614
9492506385
MDR Report Key16449137
MDR Text Key310318184
Report Number2015691-2023-11130
Device Sequence Number1
Product Code NPT
Combination Product (y/n)N
Reporter Country CodeUS
PMA/PMN Number
P140031
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Foreign,Health Professional,User Facility,Company Representative
Reporter Occupation Physician
Type of Report Initial,Followup
Report Date 04/05/2023
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received02/27/2023
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Device Expiration Date01/10/2024
Device Model Number9750TFX26
Device Catalogue NumberN/A
Device Lot NumberN/A
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Was the Report Sent to FDA? No
Date Manufacturer Received04/05/2023
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Date Device Manufactured01/10/2022
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Required Intervention;
-
-